secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-07-31T21:15:15+00:00
Accession:  0001493152-26-035672
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity receives Nasdaq delisting notice for bid price non-compliance; plans appeal
--------------------------------------------------------------------------------

- Received Staff Determination on July 30, 2026, for bid price below $1.00 for 30 consecutive business days.
- Not eligible for 180-day compliance period due to reverse stock split within prior year (1-for-30 on Sept 19, 2025).
- Intends to appeal on August 6, 2026, which will stay delisting pending panel decision.
- No assurance of regaining compliance or continued listing on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226035672/0001493152-26-035672-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226035672/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035672

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer